Regulatory News In Brief
This article was originally published in The Gray Sheet
Regulatory updates from FDA and the White House.
You may also be interested in...
A restructuring in the Office of Device Evaluation, incorporating dozens of new hires, is intended to reduce the number of reviewers reporting to each manager. It took effect last week.
The Medical Imaging & Technology Alliance does not want FDA to require warning labels for X-ray-based imaging machines that have not been tested for pediatric use.
At a recent FDA meeting on pediatric X-ray imaging, clinicians and manufacturers discussed the importance of developing size-specific dose estimates to improve children’s safety.